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Abstract
Sequencing-based DNA methylation profiling methods are comprehensive and, as accuracy and 
affordability improve, will increasingly supplant microarrays for genome-scale analyses. Here, 
four sequencing-based methodologies were applied to biological replicates of human embryonic 
stem cells to compare their CpG coverage genome-wide and in transposons, resolution, cost, 
concordance and its relationship with CpG density and genomic context. The two bisulfite 
methods reached concordance of 82% for CpG methylation levels and 99% for non-CpG cytosine 
methylation levels. Using binary methylation calls, two enrichment methods were 99% 
concordant, while regions assessed by all four methods were 97% concordant. To achieve 
comprehensive methylome coverage while reducing cost, an approach integrating two 
complementary methods was examined. The integrative methylome profile along with histone 
methylation, RNA, and SNP profiles derived from the sequence reads allowed genome-wide 
assessment of allele-specific epigenetic states, identifying most known imprinted regions and new 
loci with monoallelic epigenetic marks and monoallelic expression.
Keywords
DNA methylation; Sequencing; Bisulfite
DNA methylation plays a vital role in embryonic development, maintenance of 
pluripotency, X chromosome inactivation, and genomic imprinting through regulation of 
transcription, chromatin structure and chromosome stability1. DNA methylation occurs at 
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the C5 position of cytosines within CpG dinucleo-tides2–4 and at non-CpG cytosines in 
plants and embryonic stem cells (ESC) in mammals. 5-Hydroxymethylation of cytosine also 
occurs in certain human and mouse cells5, 6 and is catalyzed by Tet proteins acting on 
methylated cytosine. Tet1 has a role in ESC maintenance and inner cell mass cell 
specification7. Several experimental methods detect methylation but not 
hydroxymethylation, while others detect both but cannot distinguish them.
Understanding the role of DNA methylation in development and disease requires knowing 
the distribution of these modifications in the genome. The availability of reference genome 
assemblies and massively parallel sequencing has led to methods which provide high-
resolution genome-wide profiles of 5-methylcytosine8–16. In contrast to arrays, sequencing-
based methods interrogate DNA methylation in repetitive sequences, and more readily allow 
epigenetic states to be assigned to specific alleles. Each method has unique characteristics 
leaving uncertainty about the optimal method for particular biological questions. DNA 
methylation maps are being produced by many laboratories worldwide, and their integration 
forms a basis for emerging international epigenome projects17. Thus, it is critical to 
determine the precision of each method, and how reliably they can be compared.
Here, we provide a detailed and quantitative comparison of four sequencing-based methods 
for genome-wide DNA methylation profiling. We focused on two methods that utilize 
bisulfite conversion (MethylC-seq8 and Reduced Representation Bisulfite Sequencing, or 
RRBS9), and two methods that utilize enrichment of methylated DNA (Methylated DNA 
Immunoprecipitation sequencing, or MeDIP-seq10, 11 and Methylated DNA Binding 
Domain sequencing, or MBD-seq12). We also developed an integrative methodology 
combining MeDIP-seq to detect methylated CpGs, with Methylation-sensitive Restriction 
Enzyme sequencing (MRE-seq)13, 14 to detect unmethylated CpGs. Unlike the enrichment 
methods alone, the integrative method can accurately identify regions of intermediate 
methylation which, in conjunction with SNP profiling from the sequencing data, allows for 
genome-wide identification of allele-specific epigenetic states.
RESULTS
Generation of DNA Methylation Profiles from Human Embryonic Stem Cells
Four individual sequencing-based methods and one integrative method were used to 
generate and compare DNA methylation profiles of three biological replicates of H1 ESCs. 
MethylC-seq8 involves shotgun sequencing of DNA treated with bisulfite, a chemical which 
converts unmethylated cytosines but not methylated cytosines to uracil. The second 
bisulfite-based method, RRBS9, reduces the portion of the genome analyzed through an 
MspI digestion and fragment size selection. MeDIP-seq10, 11 and MBD-seq12 involve 
enrichment of methylated regions followed by sequencing. In MeDIP-seq an anti-
methylcytosine antibody is used to immunoprecipitate methylated single-stranded DNA 
fragments. MBD-seq utilizes the MBD2 protein methyl-CpG binding domain to enrich for 
methylated double-stranded DNA fragments. As a complementary approach for use in 
conjunction with methylated fragment enrichment methods, unmethylated CpGs are 
identified by sequencing size selected fragments from parallel DNA digestions with the 
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methyl-sensitive restriction enzymes (MREs) HpaII (C^CGG), Hin6I (G^CGC) and AciI 
(C^CGC)(MRE-seq)13.
To reliably identify biological variation in methylation among samples from different 
individuals or biological states, it is important to determine the variation attributable to 
biological and technical replication. As an initial assessment of DNA methylation 
concordance among three H1 ESC biological replicates, the methylation status of 27,578 
CpGs was assayed on the widely used bisulfite-based Infinium bead-array. The beta values, 
roughly representing CpG methylation levels, in the replicates were compared by calculating 
concordance correlation coefficients (CCC). The CCCs were very high, ranging from 0.992 
to 0.996 (Supplementary Fig. 1). To assess technical variation, replicate #1 and replicate #2 
were run a second time on the Infinium platform (data not shown). 98.9% of the total 
variation (technical and biological) was technical. Thus, platform comparisons using these 
replicates should be very informative.
As a second and more genome-wide analysis of variation in methylation calls, RRBS, 
covering approximately 1.6 million CpGs, was performed on all three biological replicates. 
The correlation between the biological replicates was high for RRBS (Supplementary Fig. 2) 
as it was for MeDIP-seq and MRE-seq (Supplementary Fig. 3). These results show that cell 
passage-related “biological variation” in methylation is present but minimal on a genome-
scale. The rare biological variation in methylation levels was confirmed by pyrosequencing 
of selected loci (Supplementary Fig. 4, Supplementary Table 1).
Several algorithms are available for bisulfite-treated short read mapping, differences in 
which might alter local read density in a map, and ultimately impact methylation calls. Our 
assessment of overall concordance between aligners, including Bowtie18, BSMAP19, 
Pash20, RMAP21 and ZOOM22 applied to a subset of the MethylC-seq data9, indicated 
that, despite differences in speed and accuracy, aligner choice was unlikely to have a 
significant impact on the platform comparisons (Supplementary Table 2).
There are several important parameters in choosing an appropriate method for particular 
experimental goals, including the total number and local context of CpGs interrogated and 
the amount of sequencing required. To determine the impact of sequencing depth on 
coverage, we plotted CpG coverage genome-wide (Fig. 1c) and in CpG islands (CGIs) (Fig. 
1d) as a function of read coverage threshold for CpGs. For MeDIP-seq and MBD-seq, the 
CpG coverage does not include CpGs for which a lack of methylation could be inferred from 
lack of reads (Fig. 1c–d). Thus, because CGIs are predominantly unmethylated, the CpG 
coverage in CGIs is lower than either RRBS or MethylC-seq. As an indicator of the cost 
efficiency for each method, we also graphed CpG coverage normalized to a single Gbp of 
sequence depth in the methylome maps (Supplementary Fig. 5). Enrichment methods had 
the lowest cost per CpG covered genome-wide, while RRBS had the lowest cost per CpG 
covered in CGIs. For the enrichment methods we examined the potential effect of CpG 
density on read coverage. While most of the genome is methylated and CpG poor, a small 
fraction is unmethylated and CpG rich (i.e. CGI). Consistent with this, MeDIP-seq and 
MBD-seq enrich primarily for low CpG density regions, along with a small subset of 
methylated CGIs. In contrast, MRE-seq interrogates higher CpG density regions because 
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they have an abundance of unmethylated recognition sites for these enzymes. Therefore, the 
coverage of MRE-seq and enrichment methods is notably complementary (Supplementary 
Fig. 6).
A major advantage of the sequencing-based methods over microarrays is their ability to 
interrogate CpGs in repetitive elements. Approximately 45% of the human genome is 
derived from transposable elements, a major driving force in the evolution of mammalian 
gene regulation23, 24, with nearly half of all CpGs falling within these repetitive regions. 
The extent to which different sequencing-based methods interrogate repeats is therefore of 
significant interest. In general, genome-wide CpG coverage was proportional to CpG 
coverage in repeats (Fig. 1a, c). The percent of interrogated CpGs in repeats was similar 
across all four methods, with MBD-seq capturing the highest fraction of repeat sequences 
(59.1%). Each of these methods is therefore useful for investigating this important and 
largely unexplored area. MRE-seq however, only minimally interrogates repeats, consistent 
with their dense methylation.
Only CpGs interrogated in common can be compared directly. The intersections of CpGs 
covered by the four methods were therefore determined (Fig. 1b). Overall, MethylC-seq 
provided the highest CpG coverage at 95% followed by MeDIP-seq at 67% and MBD-seq at 
61%. RRBS covered the fewest CpGs genome-wide (12%), which drove the overlap of all 
methods to 6% of genome-wide CpGs.
For any given method, how deeply to sequence the library is an open question. As the 
sequencing depth increases, the number of unique reads covering a particular region 
approaches the total possible reads present in the library for each enriched region. This 
saturation occurs when further sequencing fails to discover additional regions above 
background. To understand the extent to which we sampled the regions represented in the 
RRBS, MeDIP-seq, and MBD-seq libraries, saturation analysis was performed. RRBS 
approaches but does not reach saturation at the current sequencing depth (Supplementary 
Fig. 7a). For MeDIP-seq and MBD-seq, saturation was observed when false discovery rate 
thresholds were applied, but not when unthresholded data were plotted (Supplementary Fig. 
7b–c). Saturation was not observed for MRE-seq (Supplementary Fig. 7d–e), although the 
average restriction site was represented 13 times within each library, indicating that 
additional reads would mostly re-sample restriction sites already interrogated. Sequencing 
beyond saturation improves confidence in the observations and increases the CpG coverage, 
though at greater cost per CpG covered. Thus, sequencing below or up to saturation 
maximizes the number of samples that can be analyzed, while sequencing beyond saturation 
maximizes CpG coverage and improves confidence in methylation calls.
Comparison of Bisulfite-based Methods
Several observations from the CpG coverage analysis of MethylC-seq and RRBS are 
important to consider before assessing their concordance in methylation calls. First, RRBS 
provides substantial coverage of CpGs in CGIs, but low CpG coverage genome-wide (Fig. 
1c–d). In contrast, MethylC-seq offers greater CpG coverage genome-wide. When coverage 
is normalized to one Gbp of sequence in the methylome map, RRBS shows higher coverage 
of CpGs in CGIs at all read depths (Supplementary Fig. 5). This difference points to RRBS 
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as the method of choice if CGIs are the main focus of a study. However, at lower but still 
significant read thresholds, MethylC-seq samples far more CpGs in CGIs than RRBS.
A major advantage of bisulfite-based methods is that they allow quantitative comparisons of 
methylation levels at single base resolution. For MethylC-seq and RRBS, we calculated and 
compared the proportion of methylated reads at individual CpGs genome-wide. High 
concordance was observed using a simple method that makes methylation status calls at 
different minimum read depths and allows multiple methylation value cutoffs to be 
examined (Fig. 2a). The difference in methylation proportions (MethylC-seq - RRBS) at a 
minimum read depth of 5 was calculated for individual CpGs and concordance was declared 
if the difference did not exceed a given threshold (Fig. 2b). Of the CpGs compared between 
MethylC-seq and RRBS just 12.75% displayed identical methylation level, or a difference 
threshold of zero. If the difference threshold is relaxed to 0.1 or 0.25, the concordance 
increases to 53.85% or 81.82%, respectively. This analysis was also performed at minimum 
read depths of 2 and 10 (Supplementary Fig. 8a–b) which, for the 0.25 threshold, showed 
concordance of 80.28% and 83.89%, respectively, demonstrating that read depth has only a 
modest effect on concordance. We also performed this analysis on MethylC-seq on replicate 
#3 compared to RRBS on replicate #1 and #2, which showed a similar concordance (79.64% 
for #3 - #1; 82.95% for #3 - #2) (Supplementary Fig. 8c–f), while the concordance between 
MethylC-seq and RRBS both on replicate #3, (81.82%), falls between the concordances for 
different replicates. RRBS on replicate #1 and #2 was also compared (Supplementary Fig. 
8g–h) and showed a higher concordance (91.54%) than any of the comparisons between 
MethylC-seq and RRBS, consistent with their high correlation coefficient (Supplementary 
Fig. 2). The RRBS and MethylC-seq discordant calls were not attributable to the local CpG 
density or genomic context of the individual CpGs (Fig. 2c–d). Taken together, these 
analyses suggest differences between replicates are attributable to technical or stochastic 
factors as well as modest biological variation.
Given the notable presence of non-CpG cytosine methylation in H1 ESC8, we also 
examined concordance between MethylC-seq and RRBS at CHH and CHG cytosines. Since 
CHH sites are asymmetric with respect to strand and 98% of CHG sites are hemi-
methylated8, reads mapping to each strand were considered separately. When non-CpG 
cytosines were considered, either with (Supplementary Fig. 9) or without the zero (lack of 
methylation),methylation proportions (Supplementary Fig. 10), concordance was higher than 
concordance at CpGs. However, a lower degree of variation at non-CpG sites is expected 
because of the relatively narrow range of methylation levels for non-CpG sites.
For both CpG (Fig. 2b) and non-CpG cytosine (Supplementary Fig. 9 and 10) methylation, 
MethylC-seq showed slightly higher methylation proportions than RRBS on the same DNA, 
as demonstrated by the longer tail on the positive side of the graphs. This trend was also 
observed in comparisons of MethylC-seq to RRBS performed on replicate #1 and #2 
(Supplementary Fig. 8c–f), suggest-ing that technical aspects are driving this difference.
Comparison of Methylated Cytosine Enrichment Methods
Concordance analyses for enrichment methods differ from bisulfite methods in two 
fundamental ways. First, binary methylation calls are used in enrichment methods, since 
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methylation levels are not easily determined. Second, because of the lack of single CpG 
resolution inherent in enrichment methods, a windows based approach is used. The windows 
can include CpGs that are not directly covered by a read. Thus the percent of genome-wide 
CpGs contained in the compared windows is naturally higher than the percent of individual 
CpGs that overlap in the coverage comparison (Fig. 1b). We therefore assessed concordance 
between MeDIP-seq and MBD-seq by comparing binary highly methylated and weakly 
methylated calls from the average methylation across 1000bp and 200bp windows (see 
methods). For both window sizes, concordance was >90% at all read depths examined and 
improved with increasing minimum read depths (Fig. 3a). We confirmed the concordance 
between MeDIP-seq and MBD-seq at selected loci by bisulfite, PCR, cloning and 
sequencing (Supplementary Fig. 11, Supplementary Table 3). The substantially higher 
concordance relative to the bisulfite-based methods is in part related to the inference 
common to both enrichment methods that neighboring CpGs within a given window have 
similar methylation levels, and to the binary rather than quantitative methylation calls.
When applied in the context of the enrichment methods, the minimum read depths limit the 
analysis to regions with at least a minimal methylation level. At sufficiently high sequencing 
depth however, greater confidence can be placed in the lack of methylation inferred from 
lack of reads. However, at lower sequencing depth, lack of methylation cannot be 
distinguished from lack of coverage due to the stochastic nature of read coverage. This is an 
important difference from the bisulfite-based methods which can identify unmethylated 
regions at a sequencing depth well below saturation.
The 1000bp windows covered at a minimum read depth of 5, representing 99.8% 
concordance, were examined for potential biases related to CpG density (Fig. 3b) and 
genomic context (Fig. 3c) on concordance between MeDIP-seq and MBD-seq calls. 
Concordant and discordant calls were similar in their genomic context, but discordant calls 
were shifted toward regions of lower CpG density compared to concordant calls. Thus, 
while these two methods differ in the extent of CpG coverage and read depth at sites 
covered (Fig. 1), in windows with even minimal coverage by both methods, the concordance 
is exceptionally high. To further examine the accuracy of the calls, we compared the 
methylation calls from MeDIP-seq to those from MethylC-seq. For regions with methylation 
detectable by MethylC-seq, MeDIP-seq and MBD-seq call highly methylated in nearly 
every case (Fig. 3d).
To examine the reliability of an enrichment based method specifically for inferring weakly 
methylated regions at different CpG densities, we compared MeDIP-seq to MethylC-seq 
(Supplementary text and Supplementary Fig. 4). These analyses and limited validation by 
pyrosequencing suggest that MeDIP-seq allows accurate inferences of lack of methylation/
weak methylation in regions of high and medium CpG density, while accuracy is moderately 
reduced in low CpG density regions. Thus, increasing the sequencing depth of MeDIP-seq 
or using a complementary methodology targeting unmethylated CpGs may be useful.
Although MeDIP-seq and MBD-seq methylation calls are highly concordant, interesting 
differences exist between the regions each interrogates, and their sensitivity to detect non-
CpG methylation. First, their rate of enrichment differs slightly with respect to local CpG 
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density, with MeDIP-seq enriching more at regions with relatively low CpG density and 
MBD-seq enriching more at regions with slightly higher CpG density (Supplementary Fig. 
6), which is also reflected in their moderate (46.33%) overlap in CpG coverage. Second, the 
ability of MeDIP-seq or MBD-seq to detect non-CpG methylation could be particularly 
important for evaluating the methylome of ESC which contains abundant non-CpG 
methylation9. To address this, read densities were examined in gene bodies with similar 
CpG methylation levels but different CHG methylation levels as measured by MethylC-seq. 
MeDIP-seq signal increased with increasing non-CpG cytosine methylation, while MBD-seq 
did not (Supplementary Fig. 12), suggesting a differential sensitivity in these two 
enrichment methods. However, the power to distinguish CpG methylation signal from CHG 
methylation signal is low, since non-CpG cytosine methylation is of-ten embedded within 
regions with high CpG methylation. As a negative control, regions in the genome that 
contain no CpGs were examined. MeDIP-seq and MBD-seq had only background level 
reads, consistent with the non-CpG cytosines being unmethylated in these regions 
(Supplementary Fig. 13).
Comparison of All Methods
To examine concordance of CpG methylation calls from the two bisulfite-based methods 
and the two methylation enrichment-based methods, a four-way comparison was performed. 
This can be viewed as combining the two previous pair-wise comparisons, but with three 
differences. First, to make the bisul-fite-based methods comparable to the highly/weakly 
methylated categorization of MeDIP-seq/MBD-seq scores, a binary calling scheme was 
applied with highly methylated defined as >0.20 methylation and weakly methylated defined 
as <= 0.20 methylation. When this calling scheme for individual CpGs was applied to 
bisulfite-based data alone, the concordance between methods was 94.14% for 2 reads, 
96.15% for 5 reads and 97.13% for 10 reads. Second, in order to perform the comparison at 
the same level of resolution, the methylation proportions for individual CpGs in MethylC-
seq and RRBS were averaged across windows. Third, in order to compare the bisulfite-based 
methods to the enrichment based methods without inferring an unmethylated state from 
complete absence of reads in enrichment methods, the comparison excluded regions lacking 
reads.
Methylation calls were made for 1000bp windows where all of the methods had at least one 
CpG covered by a minimum of 5 or 10 reads allowing for comparison of 199,438 or 87,363 
windows respectively. Of all the windows covered by a minimum of 5 reads, 2.45% 
completely encompassed CGIs and 5.5% overlapped with CGIs. The four-way comparison 
revealed a high degree of concordance of methylation calls among all methods (Fig. 4a–b 
and Supplementary Table 4). To investigate the effect of applying different highly/weakly 
methylated cutoffs to MethylC-seq and RRBS, we performed the 4-way comparison at 
several cutoffs (Supplementary Fig. 14). Concordance remained above 90% up to a highly/
weakly methylated cutoff of 0.55, suggesting the concordance results we report are 
applicable to a wide range of methylation call cutoffs. This result is congruent with the 
known partitioning of the genome into methylated and unmethylated zones.
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Since the limited coverage by RRBS constrained the number of windows that could be 
compared, a three-way comparison excluding RRBS was also performed. This allowed for 
the comparison of 444,494 1000bp windows, or 32% of CpGs genome wide compared to 
18% in the 4-way comparison, which showed a three-way concordance of 99.69%. Using 
different minimum read depth and window sizes had little effect on concordance 
(Supplementary Table 5a and 5b).
To further evaluate the performance of the four methods, we compared them individually to 
the widely used Infinium bead-array. For the bisulfite-based methods, the differences in 
methylation for individual CpGs compared to beta values from the array assaying replicate 
#3 were calculated. At a difference threshold of 0.25, high concordance was observed 
between the array and MethylC-seq (96.41%; 20,885 CpGs) and between the array and 
RRBS (97.31%; 5,475 CpGs) (Supplementary Fig. 15). For the enrichment-based methods, 
the average methylation score was calculated for CpGs covered by a minimum of 5 reads in 
200bp windows centered on CpGs assayed by the array, and used to make the binary 
methylation call. For the array assaying replicate #2, highly methylated was defined as 
>0.20 beta value and weakly methylated defined as <= 0.20 beta value. Both MeDIP-seq 
(96.19%; 4960 windows) and MBD-seq (90.80%; 4163 windows) calls showed high 
concordance with the array. This high degree of agreement between very different methods 
further supports the validity of comparing methylation profiles across platforms.
Integrative Method
To increase DNA methylome coverage while maintaining modest sequencing requirements, 
MeDIP-seq was integrated with MRE-seq13. The methylation scores from MRE-seq were 
inversely correlated with MeDIP-seq scores (Fig. 5a). The two methods combined assessed 
the DNA methylation status at 22 million CpGs (Fig. 5b). In regions where MRE-seq scores 
were high and MeDIP-seq scores were low, the MRE-seq reads corroborate the lack of 
methylation inferred from the absence of MeDIP-seq reads.
Interestingly, there are a small but significant number of CGIs with overlapping MeDIP-seq 
and MRE-seq signals (Supplementary Table 6), indicating an intermediate methylation 
level. We tested two regions from one locus, ZNF331, by clonal bisulfite sequencing (Fig. 
5c–d, Supplementary Table 7). Region 1 of ZNF331 showed overlap of signals from 
MeDIP-seq and MRE-seq, with bisulfite sequencing confirming intermediate and potentially 
monoallelic methylation. In contrast, region 2 exhibited MeDIP-seq signal only, and 
bisulfite sequencing confirmed nearly complete methylation. Interestingly, ZNF331 exhibits 
monoallelic expression in CEPH pedigrees25, 26, and allelic skewing in DNA methylation 
arrays27, supporting a provisional status of ZNF331 as a novel imprinted gene. Histone H3 
lysine 4 trimethylation (H3K4me3), a mark enriched at promoters, overlapped with region 1 
but not region 2 (Fig. 5c). A third CGI at the 5’ end of ZNF331 was fully unmethylated, and 
had an even stronger H3K4me3 peak. Thus, our integrative approach identified a 
differentially methylated region (DMR) in ZNF331 that may be a DNA methylation 
regulated promoter for one of the ZNF331 transcripts.
The analysis of ZNF331 suggested the possibility of using MeDIP-seq and MRE-seq to 
generate a list of candidate DMRs genome-wide (Supplementary Tables 6–7). Ultimately 
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this could define all regions with an intermediate methylation level, encompassing DMRs of 
the human imprintome and sites of non-imprinted allelic epigenetic regulation. Consistently, 
our candidate list includes 16 of 19 DMRs of imprinted genes, including BLCAP, GRB10, 
H19, INPP5F, KCNQ1, MEST, SGCE, SNRPN, ZIM2, GNAS, GNASAS, DIRAS3, DLK1, 
NDN, PLAGL1, and TP73. Two of the known DMRs, in PEG3 and MEG3, appeared mostly 
methylated, potentially representing loss of imprint marks28. One of the 19 known DMRs 
(for NAP1L5) is not within a CGI but did in fact exhibit intermediate methylation 
(Supplementary Fig. 16). Thus, extension of this analysis to include CpG rich regions that 
are not strictly CGIs will be useful. The data indicate intermediate DNA methylation states 
that characterize DMRs within known imprinted regions and others are readily identifiable 
using an integrative approach.
Intersections of Monoallelic DNA Methylation, Histone Methylation, and Gene Expression
Sequencing-based methods present a unique opportunity to assign epigenetic marks and 
gene transcripts to specific alleles. We explored this possibility in the ESCs by identifying 
SNPs within sequence reads, focusing on the top 1000 CGI loci with extensive overlap 
between MRE-seq and MeDIP-seq signals (Fig. 6a, Supplementary Table 8–9). Of the 1000 
loci examined, 203 contained an informative SNP and 63 of these exhibited monoallelic 
DNA methylation (Fig. 6a). The remaining 140 of the 203 loci with an informative SNP 
represent intermediate methylation states that may reflect heterogeneity in methylation 
across the cell population. In total, 119 of the 1000 loci exhibited evidence of monoallelic 
epigenetic modification and/or expression. Four DMRs were identified that were 
monoallelic in DNA methylation and histone methylation, and were associated with a gene 
exhibiting monoallelic expression (Supplementary Fig. 17). Strong corroborating evidence 
for monoallelic DNA methylation was obtained from similar analyses of the MethylC-seq 
data (Supplementary Fig. 18). These results demonstrate the excellent capabilities of 
sequencing-based epigenomic and transcriptome assays for identifying genes exhibiting 
monoallelic epigenetic marks and monoallelic expression.
To further assess the accuracy of methylation status predictions, 8 regions (total of 17 non-
overlapping PCR products) which exhibited apparent monoallelic methylation from the 
MeDIP-seq and MRE-seq SNP analyses (Fig. 6a and Supplementary Table 8) were selected 
for clonal bisulfite sequencing. Adjacent CGI loci containing only MRE-seq reads were 
confirmed to be largely unmethylated (Fig. 6b), while loci containing only MeDIP-seq reads 
were heavily methylated (Supplementary Table 7). Individual bisulfite clones from two 
known imprinted genes INPP5F and GRB10 were either methylated or unmethylated at 
nearly all CpGs (Fig. 6b and Supplementary Table 7). GRB10 exhibited DNA methylation 
consistent with an isoform-specific imprint mark, as previously reported29. Seven (BCL8, 
FRG1, ZNF331, IAHI, MEFV, POTEB, ZFP3) of the eight putative DMRs showed evidence 
of differential methylation (Fig. 6c and Supplementary Table 7). Bisulfite analysis of a 
DMR upstream of POTEB at 15q11.2 provided direct evidence for allele-specific 
methylation (Fig. 6c, lower panel). The H3K9me3 signal at this locus is also monoallelic, as 
two nucleotides identified as heterozygous from the MethylC-seq reads both showed only a 
single allele in the H3K9me3 sequence reads (chr15:19346665, T in 4 of 4 reads; and 
chr15:19348112, C in 13 of 14 reads). In the 150 kb proximal to POTEB, three additional 
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CGIs exhibit intermediate methylation levels, including one near the non-coding RNA, 
CXADRP2, and one encompassing the 5’ end of BCL8. The allelic pattern of DNA 
methylation of BCL8 was confirmed by bisulfite sequencing (Supplementary Table 7).
DISCUSSION
A quantitative comparison of four sequencing-based DNA methylation methods revealed 
that all four methods yield largely comparable methylation calls, but differ in CpG coverage, 
resolution, quantitative accuracy, efficiency and cost. The greater coverage provided by 
MethylC-seq comes at more than a 50 fold increase in cost compared to RRBS, MeDIP-seq 
and MBD-seq.
The methods also differ in their ability to detect methylation at non-CpG cytosines and to 
discriminate it from CpG methylation. However, the high degree of concordance, 
approaching 100% between MeDIP-seq and MBD-seq, suggests this differential ability to 
detect non-CpG methylation does not have a significant impact on the relative methylation 
levels within 1000 bp windows. This observation may be related to the low levels of 
methylation at non-CpG sites, and their presence in regions with high CpG methylation.
Our finding that MeDIP-seq enriches for regions with lower CpG density compared to 
MBD-seq is seemingly in contrast to the finding by Li et al.30 that MeDIP-seq was more 
sensitive to regions of high CpG density than MBD-seq. However, they also show that 
increasing eluent salt concentrations in MBD-seq enriches for increasingly higher CpG 
densities. Our comparison between MeDIP-seq and MBD-seq used a salt concentration of 
1M compared to 700mM used by Li et al, which could account for the differences.
Variation in DNA methylation is a topic of wide interest. Variation may be between 
individuals, cell and tissue types, or within one cell type over time. Our biological replicates 
displayed variation that was similar in magnitude to variation from limited technical 
replicates, suggesting the concordance estimates may be marginally higher than what we 
report. Thus, to identify potentially rare variation in methylation between biological 
samples, the magnitude of technical variation should be considered.
There are numerous opportunities to increase methylome coverage. First, for RRBS or 
MRE-seq for example, selecting additional enzymes, increasing the size range of selected 
fragments, and increasing sequencing depth could dramatically increase CpG coverage. 
Second, increasing read length or employing paired-end sequencing could also positively 
impact each method. Third, integrative approaches could include MeDIP-seq or MBD-seq 
coupled with MRE-seq or RRBS, particularly for direct rather than inferred calling of 
unmethylated CpGs within high CpG density regions. Versatile methods such as Bisulfite 
Padlock Probes allow more targeted profiling, and could also complement the enrichment 
methods14.
Sequencing-based methods are unique in that they allow assessment of the methylation 
status of repetitive elements which encompass nearly half of all CpGs in the methylome. 
The epigenetic status of this entire genomic compartment has been inaccessible to 
microarrays, but is a critical component of epigenetic gene regulation, as many of the 
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sequences have regulatory function 23, 31. Furthermore, the labile DNA methylation status 
of a particular transposon in the agouti locus influences phenotype in mice, including 
susceptibility to diabetes and cancer32, 33. These and other studies indicate that there is a 
great deal to be learned about the epigenetic regulation of these abundant but enigmatic 
elements.
Sequencing-based methylation analysis methods are also unique in that the sequence reads 
themselves can be used to construct a partial map of genetic variation, including common 
and rare variants. The comprehensiveness of the genetic map is a function of read coverage 
and whether reads contain 3 nucleotides (bisulfite methods) or 4 nucleotides (enrichment 
methods). The sites of genetic variation enable local epigenetic states to be associated with 
specific alleles. SNP microarrays have been similarly deployed for allelic DNA methylation 
analysis, but the detection of variants is confined to those present on the microarray34. Our 
combined epigenomic-genomic analyses identified all CGI with intermediate methylation 
states in H1 ESCs, many of which were confirmed as monoallelic. This represents an initial 
step towards characterizing the human imprintome and genome-wide monoallelic epigenetic 
states, a goal of basic biological and clinical importance in epigenomic research.
METHODS
Embryonic Stem Cells—H1 cells were grown in mTeSR1 medium35 on Matrigel (BD 
Biosciences, San Jose, California) for 10 passages on 10cm2 plates and harvested at passage 
27. Cells were harvested by scraping prior to snap freezing for DNA isolation. Cells were 
also harvested from passage 30 and 32, and divided for isolation of DNA, RNA and 
chromatin.
Illumina Infinium Methylation Assay—Five hundred ng genomic DNA were used per 
sample for the Infinium methylation assay (Illumina, San Diego, CA), which measures 
methylation at 27,578 CpGs, with approximately 2 probes per gene (14,475 RefSeq genes). 
Bisulfite conversion was performed with the EZ DNA methylation kit (Zymo Research, 
Orange, CA) and each sample was eluted in 12 μl water. Amplification and hybridization to 
the Illumina HumanMethylation27 BeadChip were carried out according to manufacturer’s 
instructions at the UCSF Genomics Core Facility. Beta values, representing quantitative 
measurements of DNA methylation at individual CpGs, were generated with Illumina 
GenomeS-tudio software. Beta values were normalized to background and filtered to 
remove those with low signal intensity, and the filtered data were used for all subsequent 
analysis.
Shotgun bisulfite sequencing (MethylC-seq)—As described in Lister et al.8.
Reduced Representation Bisulfite Sequencing (RRBS)—RRBS analysis was 
performed as described previously36, 37, using approximately 30 ng of H1-derived DNA as 
input. The steps of the experimental protocol were as follows: (i) DNA digestion using the 
MspI restriction enzyme, which cuts DNA at its recognition site (CCGG) independent of the 
CpG methylation status. (ii) End repair and ligation of adapters for Illumina sequencing. (iii) 
Gel-based selection of DNA fragment sizes ranging from 40bp to 220bp. (iv) Two 
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successive rounds of bisulfite treatment, after which we observed 98.4% converted cytosines 
outside of CpGs. Due to the presence of non-CpG methylation in ESC, this value is an 
underestimate of the actual bisulfite conversion rate. (v) PCR amplification of the bisulfite-
converted library and sequencing on the Illumina Genome Analyzer II according to the 
manufacturer’s protocol.
A total of 2 lanes were sequenced, and the data were processed using Illumina’s standard 
pipeline for image analysis and base calling. The alignment was performed using custom 
software developed at the Broad Institute9. The non-RepeatMasked reference sequence is 
generated by size-selecting from an in-silico digest with the MspI restriction enzyme, and 
prior to the alignment all Cs in the reference sequence and in the aligned reads are converted 
into Ts. The alignment itself uses a straightforward seed-and-extension algorithm, 
identifying all perfect 12bp alignments and extending without gaps from either end of the 
seed. The best alignment is kept only in cases where the second-best alignment has at least 
three more mismatches, while all reads that match multiple times are discarded. The DNA 
methylation level of a specific CpG is calculated as the number of C-to-C matches between 
the unconverted reference sequence and the aligned read sequence divided by the sum of 
number of C-to-C matches and C-to-T mismatches.
Methylated DNA Binding Protein sequencing (MBD-seq)—3 μg of gDNA isolated 
as described above was sheared to ~300 bp using the Covaris E210 sonicator (Covaris Inc. 
Woburn, MA) and size separated by PAGE (8%). The 200–400bp DNA fraction was 
excised, eluted overnight at 4°C in 200μl of elution buffer (5:1, LoTE buffer (3 mM Tris-
HCl, pH 7.5, 0.2 mM EDTA)-7.5 M ammonium acetate) and purified using a QIAquick 
purification kit (Qiagen, Mississauga, ON). The size selected DNA was end-repaired, A-
tailed, and ligated to 2.5mMol of “paired-end” adapters (IDT Inc.) following the 
manufactures recommend protocol (Ilumina Inc.). The resulting product was purified on a 
Qiaquick MinElute column (Qiagen, Mississauga, Ontario) and assessed and quantified 
using an Agilent DNA 1000 series II assay and Qubit fluorometer (Invitrogen, Carlsbad, 
CA) respectively. 100ng of pre-adapted, size selected product was subjected to 
immunoprecipitation using the MethylMiner Methylated DNA Enrichment Kit (Invitrogen) 
following the manufactures recommended protocol. The bound fraction was eluted at 
600mM, 1M and 2M NaCl and concentrated by the addition of 1μl (20ug/ul) mussel 
glycogen, 1/10th v/v 3M sodium acetate (pH5.2) and 2× v/v 100% ethanol. Samples were 
incubated at −80°C for 2 hours and subsequently centrifuged for 15 minutes at 14,000rpm at 
4°C. Pellets were washed with 500μl cold 70% ethanol 2 times with 5 minute centrifugation 
at 14,000rpm at 4°C between washes and resus-pended in 60μl nuclease-free water. 
Following purification eluted products were subjected to PCR using Illumina paired-end 
adapters (Illumina Inc.) with 15 cycles of PCR amplification. PCR products were purified on 
Qiaquick MinElute columns (Qiagen, Mississauga, Ontario) and assessed and quantified 
using an Agilent DNA 1000 series II assay and size separated by PAGE (8%). The 320–
520bp DNA fraction was excised and purified as described above. The products were 
assessed and quantified using an Agilent DNA 1000 series II assay and Qubit fluorometer 
(Invitrogen, Carlsbad, CA) respectively. A 1μl aliquot of each library was used as template 
in 2 independent PCR reactions to confirm enrichment for methylated (SNRPN promoter) 
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and de-enrichment for unmethylated (CpG-less sequence on Chr15)(see Supplementary 
Materials for primer sequences). Cycling was 95° C for 30 s, 55° C for 30 s, and 72° C for 
30 s with 30 cycles. PCR products were visualized by 1.8% agarose gel electrophoresis. 
Each library was diluted to 8nM for sequencing on an Illumina Genome Analyzer following 
the manufactures recommended protocol.
Methylated DNA Immunoprecipitation Sequencing (MeDIP-seq)—Two to five μg 
DNA isolated as described above was sonicated to ~100–500 bp with a Bioruptor sonicator 
(Diagenode). Sonicated DNA was end-repaired, A-tailed, and ligated to adapters following 
the standard Illumina protocol. After aga-rose size-selection to remove unligated adapters, 
adapter-ligated DNA was used for each immunopre-cipitation using a mouse monoclonal 
anti-methylcytidine antibody (1 mg/ml, Eurogentec, catalog # BI-MECY-0100). DNA was 
heat denatured at 95° C for 10 minutes, rapidly cooled on ice, and immunopre-cipitated with 
1 μl primary antibody per microgram of DNA overnight at 4° C with rocking agitation in 
500 μl IP buffer (10 mM sodium phosphate buffer, pH 7.0, 140 mM NaCl, 0.05% Triton 
X-100). To recover the immunoabsorbed DNA fragments, 1 μl of rabbit anti-mouse IgG 
secondary antibody (2.5 mg/ml, Jackson Immunoresearch) and 100 μl Protein A/G beads 
(Pierce Biotechnology) were added and incubated for an additional 2 hr at 4° C with 
agitation. After immunoprecipitation a total of 6 IP washes were performed with ice cold IP 
buffer. A nonspecific mouse IgG IP (Jackson Immunoresearch) was performed in parallel to 
methyl DNA IP as a negative control. Washed beads were resuspended in TE with 0.25% 
SDS and 0.25 mg/ml proteinase K for 2 hrs at 55° C and then allowed to cool to room 
temperature. MeDIP and supernatant DNA were purified using Qiagen MinElute columns 
and eluted in 16 μl EB (Qiagen, USA). Fifteen cycles of PCR were performed on 5 μl of the 
immunoprecipitated DNA using the single end Illumina PCR primers. The resulting 
reactions are purified over Qiagen MinElute columns, after which a final size selection 
(220–420 bp) was performed by electrophoresis in 2% agarose. Libraries were QC’d by 
spectrophotometry and Agilent DNA Bioanalyzer analysis, which indicated an average 
fragment size of 150bp. An aliquot of each library was diluted in EB to 5 ng/μl and 1 μl used 
as template in 4 independent PCR reactions to confirm enrichment for methylated and de-
enrichment for unmethylated sequences, compared to 5 ng of input (sonicated DNA). Two 
positive controls (SNRPN and MAGEA1 promoters) and 2 negative controls (a CpG-less 
sequence on Chr15 and GAPDH promoter) were amplified (see Supplementary Materials for 
primer sequences). Cycling was 95° C for 30 s, 58° C for 30 s, 72° C for 30 s with 30 cycles. 
PCR products were visualized by 1.8% agarose gel electrophoresis.
Calculating MeDIP-seq and MBD-seq scores for single CpGs—MeDIP-seq and 
MBD-seq reads were mapped to the non-RepeatMasked human genome assembly (hg18) 
with MAQ. An algorithm was developed to calculate methylation scores for individual 
CpGs based on MeDIP-seq or MBD-seq data. Each uniquely mapped, non-redundant 
sequence read was extended to 150bp long, representing individual DNA fragments pulled 
down in the methylation enrichment experiment. The algorithm makes two assumptions: 
first, for a given fragment, this fragment is assigned to a CpG site that is covered by this 
fragment, and the probability of assigning it to a particular CpG, when there is more than 1 
CpG is proportional to the level of methylation of the CpG site; the weighted sum of the 
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probability of all CpGs covered by this fragment is always 1. Second, for a given CpG site, 
the number of fragments assigned to it is proportional to the level of methylation of this 
CpG site. The algorithm initiates by assigning a score of 1 to all CpGs, and then it iterates 
through two steps. In the first step, fragments are assigned to CpGs based on their scores. In 
the first round, since all CpGs have the same score of 1, an equal fraction of a fragment is 
assigned to each CpG that the fragment covers, and this is done for all fragments. In the 
second step, all the fractions of reads each CpG received in step 1 are added up, and this 
weighted sum is used as a methylation score for this CpG site. Then, the first step is 
repeated; only now individual CpGs may have a different prior for assigning reads. A 
fraction of a fragment is now assigned to CpGs that fragment covers based on methylation 
scores of the CpGs, i.e., the fraction assigned to each CpG is proportional to its methylation 
score. These updated fragment counts are summed again in step 2 and used as methylation 
score for individual CpGs. The algorithm iterates through these two steps until the 
methylation scores converge. These scores are in essence CpG density normalized read 
density.
Methylation sensitive restriction enzyme sequencing (MRE-seq)—Three parallel 
digests were performed (HpaII, AciI, and Hin6I; Fermentas), each with 1 μg of DNA. Five 
units of enzyme per microgram DNA were added and incubated at 37° C in Fermentas 
“Tango” buffer for 3 hrs. A second dose of enzyme was added (5 units of enzyme per 
microgram DNA) and the DNA was incubated for an additional 3 hrs. Digested DNA was 
precipitated with sodium acetate and ethanol, and 500 ng of each digest were combined into 
one tube. Combined DNA was size-selected by electrophoresis on a 1% agarose TBE gel. A 
100–300 bp gel slice was excised using a sterile scalpel and gel-purified using Qiagen 
Qiaquick columns, eluting in 30 μl of Qiagen EB buffer. Library construction was 
performed using the Illumina Genomic DNA Sample Kit (Illumina Inc., USA) with single 
end adapters, following the manufacturer’s instructions with the following changes. For the 
end repair reaction, T4 DNA polymerase and T4 poly-nucleotide kinase were excluded and 
the Klenow DNA polymerase was diluted 1:5 in water and 1 μl used per reaction. For single 
end oligo adapter ligation, adapters were diluted 1:10 in water and 1 μl used per reaction. 
After the second size selection, DNA was eluted in 36 μl EB buffer using Qiagen Qiaquick 
columns, and 13 μl used as template for PCR, using Illumina reagents and cycling 
conditions with 18 cycles. After cleanup with Qiagen MinElute columns, each library is 
examined by spectrophotometry (Nanodrop, Thermo Scientific, USA) and Agilent DNA 
Bioanalyzer (Agilent, USA).
MRE scores—MRE-seq reads were mapped to the human genome assembly (hg18) with 
MAQ with an additional constraint that the 5’ end of a read must map to the CpG site within 
a MRE site. An MRE-score was defined for each CpG site as the number of MRE-reads that 
map to the site, regardless of the orientation, normalized by the number of million reads 
generated by the specific enzyme. An MRE-score for each genomic window (for example, 
any given 600bp window) was defined as the average MRE-score for all CpGs that have a 
score within the window.
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RNA-seq—Polyadenylated RNA was purified from 20ug of DNAse1 (Invitrogen, 
Carlsbad, CA) treated total RNA using the MACS™ mRNA Isolation Kit (Miltenyi Biotec, 
Germany). Double-stranded cDNA was synthesized from the purified polyA+ RNA using 
Superscript™ Double-Stranded cDNA Synthesis kit (Invitrogen, Carlsbad, CA) and random 
hexamer primers (Invitrogen) at a concentration of 5μM. The resulting cDNA was sheared 
using a Sonic Dismembrator 550 (Fisher Scientific, Canada) and size separated by PAGE 
(8%). The 190–210bp DNA fraction was excised, eluted overnight at 4°C in 300 μl of 
elution buffer (5:1, LoTE buffer (3 mM Tris-HCl, pH 7.5, 0.2 mM EDTA)-7.5 M 
ammonium acetate) and purified using a QIAquick purification kit (Qiagen, Mississauga, 
ON). The sequencing library was prepared following the Illumina Genome Analyzer paired 
end library protocol (Illumina Inc., Hayward, CA) with 10 cycles of PCR amplification. 
PCR products were purified on Qiaquick MinElute columns (Qia-gen, Mississauga, Ontario) 
and assessed and quantified using an Agilent DNA 1000 series II assay and Qubit 
fluorometer (Invitrogen, Carlsbad, CA) respectively. The resulting libraries were sequenced 
on an Illumina Genome Analyzeriix following the manufacturer’s instructions. Image 
analysis and basecalling was performed by the GA pipeline v1.1 (Illumina Inc., Hayward, 
CA) using phasing and matrix values calculated from a control phiX174 library run on each 
flowcell.
ChIP-seq—Protocols for the chromatin immunoprecipitation assay and Illumina library 
construction are described in details elsewhere (O’Geen et al. in press). Briefly, crosslinked 
hESC were obtained from Cellular Dynamics, chromatin was extracted and sonicated to an 
average size of 500bp. Individual ChIP assays were performed using 50μg chromatin 
(equivalent to 5×10^6 cells) and 2ug of antibody were added to each ChIP reaction. The 
histone antibodies used in this study include H3AcK9 (Milli-pore#07-352), H3me3K4 
(CST#9751S), H3me3K27 (CST#9733S), H3me3K9 (Abcam#ab8898), H3me3K36 
(Abcam#ab9050), and H3me1K4 (Abcam#ab8895). ChIP libraries were created according 
to Robertson et al. using the entire purified ChIP sample. All ChIP samples except 
H3me1K4 were amplified using paired-end Illumina primers for a total of 18 cycles. 
Libraries were then run on a 2% aga-rose gel, and the 150–500-bp fraction of the library was 
extracted and purified. The H3me1K4 library was constructed by performing size selection 
of the 200–400bp library fragment prior to a15 cycle amplification. The libraries were 
quantified using a BioAnalyzer and sequenced. ChIP-seq peaks were called using the Sole-
Search software38.
Bisulfite Pyrosequencing—Site-specific analysis of CpG methylation was performed by 
bisulfite pyro-sequencing. Genomic DNA (1.0 μg) was bisulfite modified and 
pyrosequencing was performed as previously described39. The quantitative performance of 
each pyrosequencing assay was verified by measuring methylation standards comprised of 
known proportions of unmethylated (whole genome-amplified) and fully methylated (SssI-
treated) genomic DNA40.
Comparison was performed on three combinations of DNA methylome platforms: MethylC-
seq versus reduced representation bisulfite sequencing (RRBS), and MethylC-seq versus 
methylated DNA immunoprecipitation sequencing (MeDIP-seq). H1 cell lines of different 
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passage number were used in these experiments (Batch 3 for MethylC-seq, Batch 1 for 
RRBS and MeDIP). CpGs showing > 80% difference in methylation for the MethylC-seq 
RRBS comparison or > 80% difference between the methylated proportion and the 
methylation score for MethylC-seq and MeDIP comparisons were identified and regions 
with clusters of these sites were identified for pyrosequencing. Based on the distribution of 
target CpGs we looked for genomic regions with appropriate length (within range 50bp to 
75bp), few or no non-CG cytosines, and 2 or many target CpGs. Pyrosequencing assays 
were designed and carried out in 16 regions selected for validation; 14 of these yielded 
reliable results. Genomic coordinates and primers used for pyrosequencing for the validated 
regions are listed in Supplementary Table 1.
Clonal Bisulfite Sequencing—Further validation of genome-wide data, particularly 
sites with apparent allelic DNA methylation, was performed by bisulfite sequencing. Total 
genomic DNA underwent bisulfite conversion following established protocol41 with a 
modified conversion conditions of: 95°C for 1 min, 50°C for 59 min for a total of 16 cycles. 
Bisulfite PCR primers (Supplementary Table 4) were utilized to amplify regions of interest 
and were subsequently cloned using pCR2.1/TOPO (Invitrogen). Single colony PCR and 
sequencing (QuintaraBio) provided contigs that were aligned for analysis.
Data Analyses
Comparison of CpG or non-CpG site methylation—Repeat masking of the reference 
genome assembly was not used in any of these analyses. For bisulfite-based methods, reads 
that mapped to the positive and negative strand were combined for CpG methylation 
calculations, but not for CHG and CHH methylation calculations due to the strand 
asymmetry of non-CpG methylation9. The methylated proportion was calculated for each 
CpG or non-CpG as (methylated reads/(methylated reads + unme-thylated reads)). 
Comparisons of methylation status calls were performed by imposing minimum 
requirements of 2, 5 or 10 reads covering a CpG or non-CpG site and applying varying 
methylated proportion cutoffs (0.80-0.20, 0.75-0.25, or 0.20) to make calls on the 
methylation status. Methylated proportion differences were calculated as (MethylC-seq 
proportion - RRBS proportion). Methylation proportion difference graphs were generated by 
counting the number of CpGs with a particular methylated proportion difference and 
plotting the count on the y axis. Concordance was then calculated as the percent of CpGs 
with a methylation proportion difference less than 0.1 or 0.25.
For enrichment based methods, methylation scores inferred for individual CpGs were 
averaged across CpGs covered by a varying minimum number of reads in 1000bp or 200bp 
windows. Methylation calls of highly methylated (methylation score >8) or weakly 
methylated (methylation score <= 8) were made based on the average methylation score for 
each window where at least one CpG was covered by the minimum number of reads.
Genomic Context of Concordant and Discordant CpGs—The overlap of 
concordant and discordant CpGs with annotated genes, as defined by the UCSC Genome 
Browser RefSeq Gene track (2010-01-24 version http://genome.ucsc.edu/cgi-bin/
hgTrackUi?g=refGene), was identified. In order to deal with overlapping genes and multiple 
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isoforms of genes, CpGs were classified into gene components based on the following 
prioritization order: Promoter (within 8000bp upstream of a transcription start site), Coding 
Exon, UTR, and Intron. CpGs that did not overlap with any of these gene components were 
identified as Intergenic.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Critical parameters in sequencing-based DNA methylation profiling
Sequencing statistics and CpG coverage are shown for MethylC-seq, (207 lanes, data 
analyzed here were from Lister, et al. 8.), RRBS (2 lanes), MeDIP-seq (4 lanes each), MBD-
seq (3 lanes), and MRE-seq (3 lanes each). Since the amount of sequence produced per lane 
is increasing, we also provide “Gbp of sequence” as a measure of the relative cost of each 
method. The methods differ significantly in total bases generated by the Illumina sequencer, 
total high quality bases passing Illumina chastity filtering and mapping uniquely, and total 
bases used for generating methylome maps (high quality bases passing redundancy filters) 
(a) The H1 replicates assayed and the Gbp of sequence at successive processing stages by 
each method are shown. The bisulfite-based methods and MRE-seq resolve the methylation 
status of individual cytosines, whereas the MeDIP-seq and MBD-seq read mappings are 
extended to 150bp, resulting in a maximum resolution of 150bp. This extension is applied to 
calculations of CpG coverage but is not applied to the Gbp of sequence at the processing 
stages. Coverage information is shown for repeats (primarily transposon sequences) 
genome-wide. While maximum resolution of each method is reported, resolution can be 
assessed at various levels. As the level of resolution decreases, as a consequence of 
averaging of methylation scores over a window of larger size for example, imperfect 
coverage and limited accuracy become less limiting, provided that the average score is not 
affected by systematic biases in coverage and accuracy. Thus, methylome coverage and 
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accuracy in methylation calls are a function of resolution. (b) The percentage of genome-
wide CpGs (28,163,863) covered by multiple, single or no methods are shown. The 
percentage of CpGs covered genome-wide (c) or in CGI (d) are plotted as a function of read 
coverage threshold.
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Figure 2. Comparison of bisulfite-based methods
(a) Calls of highly/partially/weakly methylated (0.80-0.20 or 0.75-0.25 cutoff) or highly/
weakly methylated (0.20 cutoff) were made for CpGs covered at several minimum read 
depths by MethylC-seq and by RRBS (both on replicate #3). The number and percent of 
genome-wide CpGs covered and the percent of concordant calls are shown for each 
minimum read depth and methylation call cutoff. (b) Differences (MethylC-seq - RRBS) in 
methylated proportions (methylated reads/(methylated reads + unmethylated reads)) for 
CpGs with a minimum coverage of 5 reads by both methods. Percentages of concordant and 
discordant methylation were determined at cutoffs of + and − 0.1 (green dashed lines) and 
0.25 (red dashed lines). (c) CpG density in a 400bp window and (d) genomic context of 
concordant and discordant CpGs at the 0.25 cutoff.
Harris et al. Page 23
Nat Biotechnol. Author manuscript; available in PMC 2011 April 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 3. Comparison of methylated DNA enrichment methods
(a) Calls of highly/weakly methylated were made by averaging methylation scores for CpGs 
covered at varying minimum read depths by MeDIP-seq or MBD-seq in 1000bp and 200bp 
windows. The number of windows, percent of genome-wide CpGs covered, and the percent 
of concordant calls are shown for each minimum read depth and window size. For the 
1000bp windows with a minimum read depth of 5, the (b) CpG density and (c) genomic 
context of the concordant and discordant windows are shown. The inset in (b) shows a 
close-up of the concordance/discordance of CpG densities consistent with CGIs. (d) For the 
1000bp windows with a minimum read depth of 5, MethylC-seq methylation proportions for 
CpGs and non-CpG cytosines covered at a minimum read depth of 5, 444,590 windows, 
were summed and the windows were binned by the sum. For each of these bins, the number 
of windows called highly methylated by MeDIP-seq or MBD-seq is shown on the left y-axis 
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and the percent of total windows with calls of highly methylated is shown on the right y-
axis. Windows with a MethylC-seq methylation proportion sum greater than 15, 
representing 83% of all windows, were called highly methylated by MeDIP-seq and MBD-
seq in 99.9% of cases. The windows with a methylation proportion sum from 1–15, 
representing 17% of all windows, were called highly methylated by MeDIP-seq and MBD-
seq in at least 99.1% of cases.
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Figure 4. Comparison of all methods
(a) The table shows the percentage of 1000bp windows with concordant and discordant 
MethylC-seq (replicate #3), RRBS (replicate #3), MeDIP-seq (replicate #2) and MBD-seq 
(replicate #2) calls at minimum read depths of 5 and 10. Methods making the same call are 
grouped together in parentheses. Calls were made for MethylC-seq and RRBS by averaging 
the methylation proportion of CpGs within the window that were covered at the minimum 
read depth and applying a highly/weakly methylated cutoff of 0.2. Calls were made for 
MeDIP-seq and MBD-seq by averaging the methylation score of CpGs within the window 
that were covered at the minimum read depth. (b) Genome browser view of the 100kb CpG 
rich Protocadherin alpha cluster (PCDHA) exemplifying the significant concordance in 
methylation status seen on a genome-wide level. For Methyl-seq and RRBS, the Y- axis 
displays methylation scores of individual CpGs. Scores range between -500 (unmethylated) 
and 500 (methylated), and the zero line is equivalent to 50% methylated. Negative scores are 
displayed as green bars and positive scores are displayed as orange bars. For MeDIP-seq 1, 
MeDIP-seq 2 and MBD-seq, the Y-axis indicates extended read density. Browsable genome-
wide views of these datasets are available at http://www.genboree.org and http://
genome.ucsc.edu/.
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Figure 5. Integrative method increases methylome coverage and enables identification of a DMR
(a) MRE-seq involves parallel digests with methylation sensitive restriction enzymes (HpaII, 
AciI, and Hin6I), selection of cut fragments of approximately 50bp–300bp, pooling the 
digests, library construction, and sequencing. For every 600bp window along chromosome 
21, MeDIP-seq scores were plotted against MRE-seq scores. The plot depicts the inverse 
relationship between MRE-seq and Me-DIP-seq signals. (b) Coverage of CpGs in the human 
genome by MeDIP-seq alone (red), MRE-seq alone (green), both (yellow), or neither 
method (no fill). Sequence from replicate #1 and #2 were used in these calculations (c) 
UCSC Genome Browser view of ZNF331in H1 ESC, showing overlap of Me-DIP-seq, 
MRE-seq and H3K4me3 (from ChIP-seq) signals at bisulfite region 1 and only MeDIP-seq 
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signal at bisulfite region 2. (d) Clonal bisulfite sequencing results for specified regions in 
ESC from replicate #1. A filled circle represents a methylated CpG and an open circle 
indicates an unmethylated CpG.
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Figure 6. Allelic DNA methylation, histone methylation, and gene expression in embryonic stem 
cells
(a) Venn diagram summarizing the number of loci exhibiting monoallelic DNA methylation, 
histone methylation or monoallelic expression, and their overlap. Allelic methylation or 
expression was determined by comparison of genetic variation between pairs of assays. To 
further evaluate the top 1000 loci (average size of 2.9kb and encompassing a CGI) with 
potential allelic DNA methylation, the following pairs of assays were used: MRE-Seq and 
MeDIP-Seq for allelic DNA methylation within the loci, MethylC-seq and expression data 
for monoallelic expression of genes associated (+/−50kb) with the loci, MethylC-seq and 
histone modifications H3K4me3 and H3K9me3 for monoallelic histone methylation within 
1kb from the loci. Evidence of genomic variation was found for 119 of 1000 loci; 4 loci in 3 
genomic locations provided confirmation of monoallelic status from all three pairs of assays; 
an additional 26 loci were confirmed by two pairs of assays. (b–c) Validation of known and 
novel DMRs identified from MeDIP-seq and MRE-seq. DMRs are presented in a UCSC 
Genome Browser window with MeDIP-seq and MRE-seq signals in human H1 ESC, along 
with bisulfite sequencing results. The results from the biological replicates (#1 and #2) were 
very similar. (b) Imprinted gene GRB10 including a known DMR (Bisulfite region 1) and an 
upstream unmethylated CGI (Bisulfite region 2). (c) Novel DMR upstream of POTEB which 
exhibits allele specific DNA methylation. Open circle indicates an unmethy-lated CpG site. 
Filled circle represents a methylated CpG site. “x” indicates absence of a CpG site due to a 
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heterozygous SNP which destroyed the 28th CpG. All clones without the CpG were 
unmethylated, while all the clones containing the CpG were methylated. Furthermore, the 
alleles could be distinguished in the sequence reads from MeDIP-seq (G, 9 of 9 reads) and 
MRE-seq (A, 30 of 30 reads).
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